{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:05:46Z","timestamp":1776747946464,"version":"3.51.2"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Diabetic retinopathy (DR) is one of the common chronic complications of diabetes mellitus, which has developed into the leading cause of irreversible visual impairment in adults worldwide. Compound Qilian tablets (CQLT) is a traditional Chinese medicine (TCM) developed for treating DR, but its mechanism is still unclear. This study explored the mechanism of action of CQLT in treating DR through metabolomics and intestinal microbiota.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Histopathologic examination of the pancreas and retina of Zucker diabetic fatty (ZDF) rats and immunohistochemistry were used to determine the expression levels of retinal nerve damage indicators ionized calcium binding adaptor molecule-1 (Iba-1) and glial fibrillary acidic protein (GFAP). Rat fecal samples were tested by LC-MS metabolomics to search for potential biomarkers and metabolic pathways for CQLT treatment of DR. Characteristic nucleic acid sequences of rat intestinal microbiota from each group were revealed using 16S rDNA technology to explore key microbes and related pathways for CQLT treatment of DR. At the same time, we investigated the effect of CQLT on the gluconeogenic pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After CQLT intervention, islet cell status was improved, Iba-1 and GFAP expression were significantly decreased, and abnormal retinal microvascular proliferation and exudation were ameliorated. Metabolomics results showed that CQLT reversed 20 differential metabolites that were abnormally altered in DR rats. Intestinal microbiota analysis showed that treatment with CQLT improved the abundance and diversity of intestinal flora. Functional annotation of metabolites and intestinal flora revealed that glycolysis\/gluconeogenesis, alanine, aspartate and glutamate metabolism, starch and sucrose metabolism were the main pathways for CQLT in treating DR. According to the results of correlation analysis, there were significant correlations between Iba-1, GFAP, and intestinal microbiota and metabolites affected by CQLT. In addition, we found that CQLT effectively inhibited the gluconeogenesis process in diabetic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, CQLT could potentially reshape intestinal microbiota composition and regulate metabolite profiles to protect retinal morphology and function, thereby ameliorating the progression of DR.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1453436","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:45:30Z","timestamp":1723783530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolomics combined with intestinal microbiota reveals the mechanism of compound Qilian tablets against diabetic retinopathy"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiangwei","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuchun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"110852","DOI":"10.1016\/j.biopha.2020.110852","article-title":"A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanisms","volume":"132","author":"Ai","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.retram.2019.01.005","article-title":"Update of inflammatory proliferative retinopathy: ischemia, hypoxia and angiogenesis","volume":"67","author":"Aouiss","year":"2019","journal-title":"Curr. Res. Transl. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"107742","DOI":"10.1016\/j.exer.2019.107742","article-title":"Duloxetine protects against experimental diabetic retinopathy in mice through retinal GFAP downregulation and modulation of neurotrophic factors","volume":"186","author":"Bahr","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/02713683.2019.1659977","article-title":"Association of retinopathy and insulin resistance: NHANES 2005\u20132008","volume":"45","author":"Bao","year":"2020","journal-title":"Curr. Eye Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"863779","DOI":"10.3389\/fcimb.2022.863779","article-title":"Mechanisms by which traditional Chinese medicines influence the Intestinal Flora and Intestinal barrier","volume":"12","author":"Che","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2337\/db15-0661","article-title":"Plasma metabonomic profiling of diabetic retinopathy","volume":"65","author":"Chen","year":"2016","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12916-021-01991-w","article-title":"Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome","volume":"19","author":"Chen","year":"2021","journal-title":"BMC Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000438970","article-title":"Diabetic retinopathy and diabetic macular edema","volume":"55","author":"Cohen","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"CD008214","DOI":"10.1002\/14651858.CD008214.pub4","article-title":"Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy","volume":"5","author":"Dervenis","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1037164","DOI":"10.3389\/fendo.2022.1037164","article-title":"Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"885650","DOI":"10.3389\/fendo.2022.885650","article-title":"Circular RNAs in diabetes mellitus and its complications","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/nu14040792","article-title":"Understanding neurodegeneration from a clinical and therapeutic perspective in early diabetic retinopathy","volume":"14","author":"Fragiotta","year":"2022","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4239\/wjd.v14.i6.862","article-title":"Alteration of intestinal microbiota is associated with diabetic retinopathy and its severity: samples collected from southeast coast Chinese","volume":"14","author":"Gu","year":"2023","journal-title":"World J. Diabetes"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1119201","DOI":"10.3389\/fendo.2023.1119201","article-title":"Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.3390\/ijms23158343","article-title":"Interactive relationships between intestinal Flora and Bile acids","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00125-010-1836-3","article-title":"Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden","volume":"53","author":"Heintz","year":"2010","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.62.10.4","article-title":"Metabolomics in diabetic retinopathy: a systematic review","volume":"62","author":"Hou","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"mjac067","DOI":"10.1093\/jmcb\/mjac067","article-title":"Activating transcription factor 3, glucolipid metabolism, and metabolic diseases","volume":"14","author":"Hu","year":"2023","journal-title":"J. Mol. Cell Biol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-023-04169-5","article-title":"Gut microbiome combined with metabolomics reveals biomarkers and pathways in central precocious puberty","volume":"21","author":"Huang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"646348","DOI":"10.3389\/fcimb.2021.646348","article-title":"Dysbiosis and implication of the gut microbiota in diabetic retinopathy","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115734099298932240308104437","article-title":"Network pharmacology and molecular docking to explore the mechanism of compound Qilian tablets in treating diabetic retinopathy","volume":"20","author":"Jia","year":"2024","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12088-021-00993-9","article-title":"The emerging biotherapeutic agent: Akkermansia","volume":"62","author":"Kalia","year":"2022","journal-title":"Indian J. Microbiol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"a040741","DOI":"10.1101\/cshperspect.a040741","article-title":"Pancreatic \u03b2-cell development and regeneration","volume":"14","author":"Kerper","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ajo.2018.08.053","article-title":"Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes","volume":"196","author":"Kim","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s13287-022-03073-x","article-title":"Advances in cell therapies using stem cells\/progenitors as a novel approach for neurovascular repair of the diabetic retina","volume":"13","author":"Lechner","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0706743716635535","article-title":"Posttraumatic stress disorder: does the gut microbiome hold the key?","volume":"61","author":"Leclercq","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0269951","DOI":"10.1371\/journal.pone.0269951","article-title":"mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/13880209.2022.2147551","article-title":"Integration of network pharmacology and intestinal flora to investigate the mechanism of action of Chinese herbal Cichorium intybus formula in attenuating adenine and ethambutol hydrochloride-induced hyperuricemic nephropathy in rats","volume":"60","author":"Li","year":"2022","journal-title":"Pharm. Biol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1006\/exer.2002.1170","article-title":"Early retinal damage in experimental diabetes: electroretinographical and morphological observations","volume":"74","author":"Li","year":"2002","journal-title":"Exp. Eye Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1016\/j.watres.2013.04.021","article-title":"Characterization of tetracycline resistant bacterial community in saline activated sludge using batch stress incubation with high-throughput sequencing analysis","volume":"47","author":"Li","year":"2013","journal-title":"Water Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.2147\/dmso.S441399","article-title":"Application of metabolomics and traditional Chinese medicine for type 2 diabetes mellitus treatment","volume":"16","author":"Li","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13020-023-00840-7","article-title":"Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt\/HIF-1\u03b1 pathway","volume":"18","author":"Liang","year":"2023","journal-title":"Chin. Med."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1108394","DOI":"10.3389\/fendo.2023.1108394","article-title":"Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"102460","DOI":"10.1016\/j.redox.2022.102460","article-title":"Capsaicin ameliorates diabetic retinopathy by inhibiting poldip2-induced oxidative stress","volume":"56","author":"Liu","year":"","journal-title":"Redox Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"930318","DOI":"10.3389\/fimmu.2022.930318","article-title":"Causal effects of gut microbiota on diabetic retinopathy: a Mendelian randomization study","volume":"13","author":"Liu","year":"","journal-title":"Front. Immunol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1172\/JCI115997","article-title":"Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study","volume":"90","author":"Magnusson","year":"1992","journal-title":"J. Clin. Invest."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.3822","article-title":"Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment","volume":"21","author":"Marquard","year":"2015","journal-title":"Nat. Med."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4239\/wjd.v8.i7.317","article-title":"Obesity, metabolic syndrome and diabetic retinopathy: beyond hyperglycemia","volume":"8","author":"Mbata","year":"2017","journal-title":"World J. Diabetes"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.2337\/db11-0026","article-title":"Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy","volume":"60","author":"McVicar","year":"2011","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1128\/MCB.00795-08","article-title":"Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1","volume":"28","author":"Milovanova","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12886-020-01677-6","article-title":"Functional assessment of early retinal changes in diabetic patients without clinical retinopathy using multifocal electroretinogram","volume":"20","author":"Mohammed","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/07853890.2021.1925150","article-title":"Influence of gut microbiota on eye diseases: an overview","volume":"53","author":"Napolitano","year":"2021","journal-title":"Ann. Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"104299","DOI":"10.1016\/j.phrs.2019.104299","article-title":"Spermine oxidase: a promising therapeutic target for neurodegeneration in diabetic retinopathy","volume":"147","author":"Narayanan","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5728674","DOI":"10.1155\/2020\/5728674","article-title":"Recent developments in diabetic retinal neurodegeneration: a literature review","volume":"2020","author":"Pillar","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11306-018-1383-3","article-title":"Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy","volume":"14","author":"Rhee","year":"2018","journal-title":"Metabolomics"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/0471142727.mb3002s98","article-title":"Targeted metabolomics","volume":"30","author":"Roberts","year":"2012","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front. Immunol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"801269","DOI":"10.1155\/2014\/801269","article-title":"Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets","volume":"2014","author":"Safi","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/EB.S69185","article-title":"Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects","volume":"8","author":"Saxena","year":"2016","journal-title":"Eye Brain"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"582060","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/life13040968","article-title":"Gut microbiota dysbiosis in diabetic retinopathy\u2014current knowledge and future therapeutic targets","volume":"13","author":"Serban","year":"2023","journal-title":"Life"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-nutr-061121-091507","article-title":"Gluconeogenesis flux in metabolic disease","volume":"43","author":"Shah","year":"2023","journal-title":"Annu. Rev. Nutr."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/ijo.IJO_928_22","article-title":"Vitreous hemorrhage\u2014causes, diagnosis, and management","volume":"71","author":"Shaikh","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09273948.2011.580073","article-title":"Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy","volume":"19","author":"Shen","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence","volume":"48","author":"Sim\u00f3","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1056-8727(00)00052-0","article-title":"Insulin resistance in diabetic microangiopathies","volume":"14","author":"Suzuki","year":"2000","journal-title":"J. Diabetes Complicat."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1038\/s41598-017-09068-6","article-title":"Histological evaluation of diabetic neurodegeneration in the retina of Zucker diabetic fatty (ZDF) rats","volume":"7","author":"Szab\u00f3","year":"2017","journal-title":"Sci. Rep."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1102361","DOI":"10.3389\/fendo.2023.1102361","article-title":"The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2018.05.004","article-title":"Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: a protective role against proliferative diabetic retinopathy","volume":"173","author":"Vidhya","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"843558","DOI":"10.3389\/fimmu.2022.843558","article-title":"Targeting microglia to treat degenerative eye diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00592-019-01363-0","article-title":"Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1007\/s10792-020-01537-8","article-title":"Retrobulbarly injecting nerve growth factor attenuates visual impairment in streptozotocin-induced diabetes rats","volume":"40","author":"Wang","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"867600","DOI":"10.3389\/fendo.2022.867600","article-title":"Identification and validation of autophagy-related genes in diabetic retinopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00125-018-4619-x","article-title":"Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial","volume":"61","author":"Welsh","year":"2018","journal-title":"Diabetologia"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00592-013-0550-2","article-title":"Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats","volume":"51","author":"Wohlfart","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","article-title":"Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy","volume":"64","author":"Xie","year":"2021","journal-title":"Diabetologia"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1116136","DOI":"10.3389\/fendo.2023.1116136","article-title":"Receptors that bind to PEDF and their therapeutic roles in retinal diseases","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/ijmm.2021.4908","article-title":"Therapeutic potential of curcumin in diabetic retinopathy (review)","volume":"47","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.04.001","article-title":"Gut microbiota changes and its potential relations with thyroid carcinoma","volume":"35","author":"Yu","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.4103\/1673-5374.391303","article-title":"Global trends in diabetic eye disease research from 2012 to 2021","volume":"19","author":"Yuan","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11892-019-1134-5","article-title":"Retinal neurodegeneration as an early manifestation of diabetic eye disease and potential neuroprotective therapies","volume":"19","author":"Zafar","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.7150\/thno.71038","article-title":"Inhibiting the activation of MAPK (ERK1\/2) in stressed M\u00fcller cells prevents photoreceptor degeneration","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/1751-7915.13410","article-title":"Akkermansia muciniphila is a promising probiotic","volume":"12","author":"Zhang","year":"","journal-title":"Microb. Biotechnol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1205846","DOI":"10.3389\/fendo.2023.1205846","article-title":"The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1096\/fj.201802614RRR","article-title":"Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1\/2-NF-\u03baB signaling pathway","volume":"33","author":"Zhang","year":"","journal-title":"FASEB J."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"CD007939","DOI":"10.1002\/14651858.CD007939.pub2","article-title":"Single herbal medicine for diabetic retinopathy","volume":"12","author":"Zhang","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"732204","DOI":"10.3389\/fcell.2021.732204","article-title":"Gut microbiota composition and fecal metabolic profiling in patients with diabetic retinopathy","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1453436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:45:33Z","timestamp":1723783533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1453436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":84,"alternative-id":["10.3389\/fmicb.2024.1453436"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1453436","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"article-number":"1453436"}}